Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Telemedicine payment expansion?
MDedge Pediatrics
Bundle pay plan didn’t save money
MDedge Pediatrics
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Pediatrics
Is fibromyalgia one disorder – or two?
MDedge Pediatrics
Is fish oil’s heart benefit a fish tale?
MDedge Pediatrics
Blood pressure meds cut cognitive impairment risk
MDedge Pediatrics
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Pediatrics
Study explores adolescents’ views on their skin tone, pressure to tan
MDedge Pediatrics
AAP: Fertility, sexual function counseling should start early
MDedge Pediatrics
Free skin cancer screening highlights need
MDedge Pediatrics